ATE57384T1 - 9-alpha-fluor- oder chlor-corticosteroide und verfahren zu ihrer herstellung. - Google Patents

9-alpha-fluor- oder chlor-corticosteroide und verfahren zu ihrer herstellung.

Info

Publication number
ATE57384T1
ATE57384T1 AT85305302T AT85305302T ATE57384T1 AT E57384 T1 ATE57384 T1 AT E57384T1 AT 85305302 T AT85305302 T AT 85305302T AT 85305302 T AT85305302 T AT 85305302T AT E57384 T1 ATE57384 T1 AT E57384T1
Authority
AT
Austria
Prior art keywords
sub
chlorine
corticosteroids
fluoroor
alpha
Prior art date
Application number
AT85305302T
Other languages
English (en)
Inventor
Ivan Villax
Philip Ronald Rua Dos Gir Page
Santo Antonio De
William Heggie
Original Assignee
Hovione Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Int Ltd filed Critical Hovione Int Ltd
Application granted granted Critical
Publication of ATE57384T1 publication Critical patent/ATE57384T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT85305302T 1984-07-25 1985-07-25 9-alpha-fluor- oder chlor-corticosteroide und verfahren zu ihrer herstellung. ATE57384T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT78973A PT78973A (en) 1984-07-25 1984-07-25 New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
EP85305302A EP0170500B1 (de) 1984-07-25 1985-07-25 9-Alpha-Fluor- oder Chlor-Corticosteroide und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE57384T1 true ATE57384T1 (de) 1990-10-15

Family

ID=20083528

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85305302T ATE57384T1 (de) 1984-07-25 1985-07-25 9-alpha-fluor- oder chlor-corticosteroide und verfahren zu ihrer herstellung.

Country Status (16)

Country Link
US (1) US5026693A (de)
EP (1) EP0170500B1 (de)
JP (2) JPS6153297A (de)
KR (1) KR880001238B1 (de)
AT (1) ATE57384T1 (de)
AU (1) AU571986B2 (de)
CA (1) CA1307257C (de)
DE (1) DE3580072D1 (de)
DK (1) DK167617B1 (de)
ES (1) ES8606878A1 (de)
HK (1) HK107990A (de)
IE (1) IE58941B1 (de)
IL (1) IL75871A (de)
NZ (1) NZ212876A (de)
PT (1) PT78973A (de)
ZA (1) ZA855621B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4333920A1 (de) 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US5981517A (en) * 1996-05-09 1999-11-09 Soft Drugs, Inc. Androstene derivatives
JP7106773B1 (ja) * 2022-01-25 2022-07-26 同仁医薬化工株式会社 ステロイド17α,21-ジエステル類の製造方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE634881A (de) * 1963-01-21
GB1047519A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡,21-diesters of 11,17,21-trihydroxy steroid compounds
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
US3876633A (en) * 1973-02-21 1975-04-08 Omni Research Processes and intermediates for 16-substituted corticoid synthesis
JPS5710417Y2 (de) * 1973-08-07 1982-03-01
ZA751599B (en) * 1974-03-27 1976-02-25 Plurichemie Anstalt 16-methyl-9alpha-halo steroid esters, ethers and preparation thereof
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
AT357696B (de) * 1974-03-27 1980-07-25 Plurichemie Anstalt Verfahren zur herstellung von 16alpha- und 16beta-methyl-9alpha-chlor- oder -fluor-21- -desoxyprednisolonestern und -aethern
YU54476A (en) * 1975-03-31 1982-05-31 Taisho Pharmaceutical Co Ltd Process for obtaining 17-ester 21-halo-pregnane
JPS5855158B2 (ja) * 1975-06-16 1983-12-08 武田薬品工業株式会社 ステロイド誘導体の製造法
CH626632A5 (en) * 1975-12-12 1981-11-30 Ciba Geigy Ag Process for the preparation of halopregnadienes
JPS5276675A (en) * 1975-12-23 1977-06-28 Seikosha Kk Method of manufacturing electrodes
DE2617655C2 (de) * 1976-04-21 1984-11-08 F. Hoffmann-La Roche & Co Ag, Basel Kortikoide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
JPS52144663A (en) * 1976-05-25 1977-12-02 Taisho Pharmaceut Co Ltd Preparation of pregnane steroid 17alpha-ester 21-halides
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung
JPS5820157B2 (ja) * 1978-02-03 1983-04-21 アルプス電気株式会社 回路板の形成方法
JPS54144823A (en) * 1978-05-04 1979-11-12 Nippon Telegr & Teleph Corp <Ntt> Keyboard of non-keying type
JPS55115216A (en) * 1979-02-27 1980-09-05 Fujitsu Ltd Method of forming movable electrode on base
DE3069074D1 (en) * 1979-11-16 1984-10-04 Sterosynt Ltd 6-alpha-9-alpha-difluoro-16-beta-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
IL66432A0 (en) * 1981-08-04 1982-12-31 Plurichemie Anstalt Process for the preparation of steroidal esters
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
KR880001237B1 (ko) * 1984-07-25 1988-07-12 호비온 인터 리미티드 베클로메타손 17,21-디프로피오네이트의 용매화합물의 제조방법
JPS61180354U (de) * 1985-04-25 1986-11-11

Also Published As

Publication number Publication date
ES8606878A1 (es) 1986-06-01
JPH037679B2 (de) 1991-02-04
US5026693A (en) 1991-06-25
PT78973A (en) 1984-08-01
EP0170500B1 (de) 1990-10-10
HK107990A (en) 1990-12-28
ES545560A0 (es) 1986-06-01
DE3580072D1 (de) 1990-11-15
ZA855621B (en) 1986-03-26
AU4530685A (en) 1986-01-30
EP0170500A3 (en) 1986-06-11
KR860001123A (ko) 1986-02-22
AU571986B2 (en) 1988-04-28
EP0170500A2 (de) 1986-02-05
JPH0215559B2 (de) 1990-04-12
NZ212876A (en) 1988-05-30
JPS6153297A (ja) 1986-03-17
IL75871A (en) 1989-05-15
DK167617B1 (da) 1993-11-29
DK334585D0 (da) 1985-07-23
DK334585A (da) 1986-01-26
IL75871A0 (en) 1985-11-29
KR880001238B1 (ko) 1988-07-12
IE58941B1 (en) 1993-12-01
IE851851L (en) 1986-01-25
JPS6354392A (ja) 1988-03-08
CA1307257C (en) 1992-09-08

Similar Documents

Publication Publication Date Title
DE3686002D1 (de) 9-(phosphonylmethoxyalkyl)-adenine, verfahren zu ihrer herstellung und ihre verwendung.
ES2164756T3 (es) Produccion de pentafluoretano.
ATE5675T1 (de) Glasartiges alkalikationleitendes material, verfahren zu seiner herstellung und eine dieses material verwendende elektrochemische zelle.
DE3865037D1 (de) Herstellung von wasserfreiem wasserstofffluorid von hoher reinheit mit einem niedrigen gehalt an arsen.
EP0285884A3 (de) Verfahren zur Herstellung von 2&#39;,3&#39;-Dideoxynucleoside
AU2979789A (en) Gas-phase reaction of 1,1,1-trifluorochloroethane with hydrogen fluoride to produce 1,1,1,2-tetrafluoroethane
HUT38352A (en) Process for production of derivatives of 6 /substituated with five-linked hetero-cyclic group/-methilene penem
ATE57384T1 (de) 9-alpha-fluor- oder chlor-corticosteroide und verfahren zu ihrer herstellung.
HUT44584A (en) Enzymatic process for preparing cyclodextrins with alpha-glycosyl fluoride as substrate of cyclodextrin-alpha-/1-&gt;4/-glycosyltransferase
FR2556166B1 (fr) Procede de fabrication continue de corps allonges en carbone
ATE99662T1 (de) Verfahren zur herstellung von 1,1-dichlor-1fluorethan.
GB2018750A (en) Methyltetrahalobenzylacrylates and methacrylates, and polymers and plastics compositions based thereon
JPS5436694A (en) Electric processing liquid and method of producing same
ATE150438T1 (de) Verfahren zur herstellung von 1,1,1,2- tetrafluorethan
ES8406507A1 (es) Procedimiento para la preparacion de hexanorbrassinolid-22-eteres
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
IT8322104A1 (it) Procedimento per la preparazione di (8S)-8-fluoroeritromicina
GB8815127D0 (en) Wall panel suitable for use as blackboard &amp; method of manufacture
ATE46316T1 (de) 3-hydroxydicarbonsaeuren und ein verfahren zu ihrer herstellung.
ES468107A1 (es) Procedimiento para la preparacion de derivados de la 9-fluo-roprednisolona
ES8606368A1 (es) Un procedimiento para producir un derivado de bencil-fosfi- nato etilico
PH18551A (en) Fluorophenoxybenzyl esters and the composition containing same
ATE114150T1 (de) Verfahren zur herstellung von 1,1,1,2- tetraflourethan.
DE3676150D1 (de) Verfahren zur herstellung von ergolinyl-thioharnstoffen.
CS187051B1 (en) New producing industrial yeast strain of microorganism candida tropicalis no 2838

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time